Nanotope

Nanotope is a regenerative medicine company that leverages a platform technology to address multiple therapeutic markets. It is developing a suite of products, each customized to regenerate specific tissues including: neuronal, vascular, cartilage, bone, and myocardial. Products are peptide-based, injectable compounds that work with surviving cells in and around th epoint of injury to initiate and support regeneration. Once regeneration is complete, the compounds are safely broken down and removed by the body.

Nanotope's lead candidates, shown to be effective in multiple animal models, target spinal cord regeneration for the reversal of paralysis, cartilage regeneration,  and advanced wound healing. Nanotope's peptide amphiphiles were first developed at Northwestern University by Dr. Samuel Stupp, Professor of Materials Science and Engineering, Chemistry and Medicine and Director of the Institute for BioNanotechnology in Medicine (IBNAM).